Study-Unit Description

Study-Unit Description


CODE PHR4112

 
TITLE Pharmacy Practice 4

 
LEVEL 04 - Years 4, 5 in Modular UG or PG Cert Course

 
ECTS CREDITS 6

 
DEPARTMENT Pharmacy

 
DESCRIPTION - Gastrointestinal System disorders:
o Control of gastric acidity and treatment of peptic ulcers
o Nausea and emesis
o Inflammatory bowel disease, constipation and diarrhoea
- Endocrine and Metabolic Disorders:
o Thyroid disorders, Diabetes, Anaemia
- Neurologic Disorders:
o Parkinsonism, Headache, Pain Management
- Rheumatic disorders, Osteoarthritis and Gout
- Bone disorders
- Cancer Chemotherapy
- Critical Care Therapeutics
- Infectious Diseases
- Techniques in Patient Counselling and Education
- Recent advances in pharmacotherapy
- Chronotherapeutics
- Pharmacy Practice and the Healthcare System
- Assessment of nutritional status and estimating nutritional requirements
- Nutrition support- oral, enteral and parenteral feeding
- Special diets- vegetarianism, allergies, modified consistency meals
- Nutrition management in coronary heart disease
- Nutrition management in diabetes
- Menu requirements and nutrition analysis of hospital meals
- Research methodology: dissemination of results, participation at the yearly symposium
- Practical experience in a community pharmacy

Study unit aims:

o to appreciate provision of pharmaceutical care in co-operation with patients, prescribers and other members of an interprofessional health care team based on therapeutic principles and evidence-based data taking into account relevant socio-economic factors, professional issues and evolving pharmaceutical technology

Learning Outcomes:

1. Knowledge & Understanding
By the end of this study unit, the student will be able to:

o propose therapeutic management of specific chronic disease states
o develop pharmaceutical care plans to meet patient needs
o integrate principles of pharmaceutical sciences into applied pharmacotherapy

2. Skills
By the end of this study unit, the student will be able to:

o Retrieve, evaluate and manage information in a critical, scientific and effective manner
o Communicate professional knowledge clearly to colleagues and patients orally and in writing
o Conduct medication use evaluations
o Evaluate and manage formulary processes
o Interact with individuals of different socio-economic background and health status to promote motivation for the adoption of healthy lifestyle habits

Main texts:

o Azzopardi L (ed). Lecture notes in pharmacy practice. 2009. London: Pharmaceutical Press
o Randall MD, Neil KE. Disease management: A Guide to Clinical Pharmacology. 2009. London: Pharmaceutical Press.
o Walker, R, Whittlesea, C. Clinical pharmacy and therapeutics. 2007. Edinburgh: Churchill Livingstone.
o Greene, RJ, Harris, N. Pathology and therapeutics for pharmacists: A Basis for Clinical Pharmacy Practice. London: Pharmaceutical Press. 2008
o Cipolle, RJ, Strand, LM, MORLEY PC. Pharmaceutical care practice. 1998. USA: McGraw Hill.
o Wright J, Gray A. Clinical Pharmacy Pocket companion. 2006, London: Pharmaceutical Press.
o Ferguson N. Osteoporosis in focus. 2004. London: Pharmaceutical Press.
o Patel A. Diabetes in focus. 2003. London: Pharmaceutical Press
o Redfern P. Chronotherapeutics. 2003. London: Pharmaceutical
o Azzopardi, L. Validation instruments for community pharmacy: Pharmaceutical care for the third millennium. 2000. Birminghamton, USA: Pharmaceutical Products Press.
o Brown, TR. ed. Handbook of institutional pharmacy practice. 1992. Bethesda: ASHP.
o McKay, AB, Hepler, CD, Knapp, DA. How to evaluate progressive pharmaceutical services. 1987. Bethesda: ASHP.
o Longe, RL, Calvert, JC., Young, YL. Physical assessment: a guide for evaluating drug therapy. 1994. Vancouver: Applied Therapeutics Inc.
o Koda-Kimble M.A, Young LY, Kradjan WA. Handbook of Applied Therapeutics. 2006. USA: Lippincott Williams & Wilkins
o Bond C. Concordance: A Partnership in Medicine Taking. 2004. London: Pharmaceutical Press.
o Bond C. Evidence-Based Pharmacy. 2000. London: Pharmaceutical Press
o Tugwell C. Parkinson’s Disease in Focus. 2007. London: Pharmaceutical Press.

 
RULES/CONDITIONS Before TAKING THIS UNIT YOU MUST TAKE PHR3106

 
STUDY-UNIT TYPE Synoptic Study-Unit

 
METHOD OF ASSESSMENT
Assessment Component/s Assessment Due Resit Availability Weighting
Logbook SEM2 Yes 5%
Online Examination (3 Hours) SEM2 Yes 95%

 
LECTURER/S Alison Anastasi
Lilian M. Azzopardi
Anthony Serracino Inglott

 
The University makes every effort to ensure that the published Courses Plans, Programmes of Study and Study-Unit information are complete and up-to-date at the time of publication. The University reserves the right to make changes in case errors are detected after publication.
The availability of optional units may be subject to timetabling constraints.
Units not attracting a sufficient number of registrations may be withdrawn without notice.
It should be noted that all the information in the description above applies to study-units available during the academic year 2020/1. It may be subject to change in subsequent years.

https://www.um.edu.mt/course/studyunit